Filter
9756
Filtered Results: 9756
Text search:
health
strategy
Featured
Recommendations
785
New Publications
2571
Language
Document type
No document type
5434
Studies & Reports
1742
Guidelines
1122
Manuals
462
Strategic & Response Plan
450
Fact sheets
231
Training Material
124
Situation Updates
95
Resource Platforms
33
Infographics
28
Online Courses
16
Brochures
15
Dashboards/Maps
2
App
1
Videos
1
Countries / Regions
Global
442
India
343
Kenya
305
Ethiopia
217
Uganda
204
South Africa
195
Sierra Leone
192
Nepal
188
Liberia
184
Nigeria
181
Myanmar / Burma
170
Western and Central Europe
169
Latin America and the Carribbean
168
Rwanda
151
Indonesia
148
Malawi
146
Zambia
144
Africa
141
Bangladesh
134
Tanzania
131
Syria
124
Ghana
112
Congo, Democratic Republic of
100
Ukraine
98
Philippines
85
Namibia
78
Eastern Europe
76
South Sudan
74
Lesotho
65
Zimbabwe
64
Brazil
60
Mozambique
59
Cambodia
59
South–East Asia Region
59
Russia
59
Guinea
58
West and Central Africa
58
East and Southern Africa
57
Senegal
55
Asia
55
Yemen
50
Haiti
46
Botswana
45
Middle East and North Africa
44
Venezuela
43
Burkina Faso
39
Colombia
38
Cameroon
35
Eastern Europe and Central Asia
34
Afghanistan
31
Pakistan
31
Germany
29
Eswatini/ Swaziland
27
Sudan
26
Benin
25
Jordan
24
Lebanon
24
Thailand
21
Central African Republic
21
Mali
21
Somalia
21
Madagascar
19
Western Pacific Region
18
Vietnam
18
Tajikistan
17
Peru
17
Paraguay
17
China
15
Iraq
15
Albania
14
USA
14
North America
13
Côte d’Ivoire / Ivory Coast
13
Angola
13
Laos
12
Ecuador
12
Turkey
11
Chile
11
Argentina
11
Moldova
11
Sri Lanka
10
Palestine
9
Georgia
9
Niger
8
Burundi
8
Libya
8
North Macedonia
7
Mexico
7
Togo
7
Guinea-Bissau
7
Southern Africa
7
Bolivia
7
Egypt
7
Chad
7
Timor Leste/ East Timor
6
Gambia
6
Iran
6
Hungary
6
Papua New Guinea
6
El Salvador
5
Kazakhstan
5
Kyrgyzstan
5
Turkmenistan
5
Jamaica
5
Portugal
5
Spain
5
Honduras
5
Malaysia
4
Saudi Arabia
4
Japan
4
Romania
4
Greece
4
Poland
4
Bhutan
4
Guatemala
4
Serbia
3
Uzbekistan
3
Italy
3
Armenia
3
Croatia
3
Mauritius
3
Tunisia
3
United Kingdom
3
Bosnia and Herzegovina
3
Canada
2
Fiji
2
Singapore
2
Estonia
2
Morocco
2
Mongolia
2
Qatar
2
Bulgaria
2
Mauritania
2
Dominican Republic
2
Lithuania
2
Azerbaijan
2
Israel
2
Nicaragua
2
Djibouti
2
Slovakia
2
North Korea
1
Vanuatu
1
Ireland
1
Gabon
1
Uruguay
1
Denmark
1
Belgium
1
France
1
Maldives
1
Norway
1
Morocco
1
Belarus
1
Latvia
1
Eritrea
1
Authors & Publishers
Publication Years
Category
Countries
3866
Clinical Guidelines
614
Key Resources
584
Public Health
560
Women & Child Health
449
Capacity Building
164
Pharmacy & Technologies
71
Annual Report MEDBOX
2
Toolboxes
COVID-19
875
HIV
741
Mental Health
584
TB
531
Planetary Health
381
Disability
362
NTDs
315
Conflict
293
Ebola & Marburg
287
AMR
280
Rapid Response
278
Caregiver
219
NCDs
186
Global Health Education
168
Refugee
146
Health Financing Toolbox
132
Natural Hazards
128
Pharmacy
128
Cholera
67
Polio
67
Zika
57
Specific Hazards
50
Social Ethics
25
Malaria
20
Typhoon
8
South Sudan
1
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
Antimicrobial resistance (AMR) represents a major global threat across human, animal, plant food and environmental sectors, threatening the effective treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi, resulting in prolonged illness and increased mor...
The plan contains the latest available evidence on the extent of insecticide resistance around the world, and puts forward a strategy for global and country levels, identifying clear roles and timelines for all stakeholders. The GPIRM also summarizes information about innovative new products being d...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
Despite being a curable and preventable disease, tuberculosis (TB) remains as one of the major challenges for health systems, globally. Every year, TB affects more than 10 million people and kills more than 1.4 million people. WHO’s Digital Health for the End TB Strategy – an Agenda for Action o...
The 2010-2011 National Annual Report on HIV program presents the progress in implementing the strategies and activities articulated in the National Strategic Plan on HIV and AIDS 2009-2012 commonly referred to as the HIV NSP. The report presents consolidated information regarding the outputs in the ...
The importance of community and civil society engagement to end TB has been highlighted in various strategies and global commitments. The WHO End TB Strategy, aligned with the United Nations Sustainable Development Goals, emphasizes the role of communities and civil society in ending the TB epidemic...
More than 700 000 people lose their life to suicide every year. The world is not on track to reach the 2030 suicide reduction targets. WHO advocates for countries to take action to prevent suicide, ideally through a comprehensive national suicide prevention strategy. Governments and communities can ...
This report summarizes the World Health Organization’s (WHO) global work on water, sanitation and hygiene (WASH) during 2022. It describes how the Organization continued to deliver its essential WASH programming as elaborated in its 2018–2025 strategy.
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im...
The Committee examined the clinical development of Ebola virus vaccines and conducted an inventory of available data on their safety. It also reviewed 3 generic issues: updating a global strategy on vaccine safety, use of a network of distributed data ...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
HIV testing programmes need to ensure that all clients who test for HIV are provided with correct diagnoses. The accuracy of HIV testing is critical to prevent misdiagnosis, as the consequences of giving an incorrect test result can be serious for clients, HIV testing services, HIV programmes and pu...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Discussion paper initially prepared in April 2015 to facilitate feedback, and finalized after the
June 2015 meeting of WHO’s Strategic and Technical Advisory Group for TB (STAG-TB).
The World Health Organization provides regional and national strategies and operational plans that aim to support countries in work to achieve measles control and elimination. These are guided by high level frameworks including the Immunization Agenda 2030 and the Measles and Rubella Strategic Frame...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
The objectives of pertussis surveillance are to:hmonitor disease burden and the impact of the pertussis vaccination programme, with a special focus on understanding the morbidity and mortality in children < 5 years of agehgenerate data to inform vaccine schedule and delivery strategy decisions to op...
Tuberculosis (TB) and particularly drug-resistant TB continue to represent major public health threats in the WHO European Region. This document details the Tuberculosis action plan for the WHO European Region 2023–2030 as well as its monitoring and evaluation framework and outlines the visi...
